Financial Results approved in the Board Meeting dated March 23, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Smallcap 250 and 2.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Rainbow Children's Medicare reported strong full-year results with standalone revenue of ₹15,456.6 million (up 6.3% YoY) and PAT of ₹2,500.2 million (up 5.2% YoY). On consolidated basis, revenue grew 12.4% to ₹17,030.8 million and PAT rose 15.3% to ₹2,815.4 million, boosted by the acquisition of Prashanthi Hospital (from July 2025) which contributed ₹191.5 million in revenue. The company recognized an exceptional item of ₹15.4 million due to provisioning for new labour codes. S.R. Batliboi & Associates issued an unmodified audit opinion. The Board recommended a dividend of ₹3.5 per share (35% payout) subject to shareholder approval at the July 2026 AGM.
Solid FY26 results with healthy revenue and profit growth. The consolidation of recent acquisitions is driving above-standalone growth rates on a consolidated basis, which is positive for scale expansion.